The ocular features of the mucopolysaccharidoses
Related Experiment Video
Updated: Aug 17, 2026

Profiling of Permethylated Mucin O-glycans Using Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry
Published on: June 20, 2025
J L Ashworth1, S Biswas, E Wraith
1Manchester Royal Eye Hospital, Oxford Road, Manchester, UK. Jane_Ashworth@btinternet.com
Aims:
The mucopolysaccharidoses (MPS) are a heterogeneous group of rare disorders characterised by accumulation of glycosaminoglycans within multiple organ systems. This study aimed to determine the prevalence and severity of ocular complications in patients with MPS.
Methods:
Clinical ophthalmic features and electrodiagnostic results of 50 patients with a diagnosis of MPS were retrospectively reviewed.
Results:
A total of 79% of MPS IH patients had a visual acuity of less than 6/12 equivalent in their better eye, compared to 44% of MPS IH/S and 25% of MPS VI patients. In total, 16% of MPS IH and 25% of MPS IH/S had severe corneal opacification, compared to 38% of MPS VI patients. 16% of MPS IH patients had optic atrophy; 21% of MPS VI patients had mild disc swelling, 29% had markedly swollen discs, and 14% had optic atrophy. One patient with MPS IH, one with MPS IH/S and six with MPS VI had ocular hypertension. One MPS VI patient had glaucoma that required topical therapy. Nine patients with MPS IH had electrodiagnostic evidence of retinopathy, as did one MPS VI patient.
Conclusions:
Ocular complications causing significant reduction in vision are common in MPS. The majority of MPS I and MPS VI patients have corneal opacification, which can lead to difficulties in diagnosis and monitoring of glaucoma, optic disc changes, and retinopathy.
Insights
Ocular complications are common in mucopolysaccharidoses (MPS), significantly impacting vision. Corneal opacification is prevalent in MPS I and MPS VI, complicating diagnosis and monitoring of other eye conditions.
Area of Science:
- Ophthalmology
- Genetics
- Rare Diseases
Background:
- Mucopolysaccharidoses (MPS) are rare genetic disorders.
- Characterized by glycosaminoglycan accumulation affecting multiple organ systems.
- Ocular manifestations are a significant concern in MPS patients.
Purpose of the Study:
- To determine the prevalence and severity of ocular complications in patients diagnosed with MPS.
- To analyze the spectrum of ophthalmic findings across different MPS subtypes.
Main Methods:
- Retrospective review of clinical ophthalmic features.
- Analysis of electrodiagnostic results from 50 MPS patients.
- Categorization of findings by MPS subtype (MPS IH, MPS IH/S, MPS VI).
Main Results:
- High prevalence of reduced visual acuity (up to 79% in MPS IH).
- Significant corneal opacification noted in MPS IH (16%), MPS IH/S (25%), and MPS VI (38%).
- Optic nerve abnormalities (atrophy, swelling) and retinopathy observed in MPS IH and MPS VI patients; ocular hypertension and glaucoma also reported.
Conclusions:
- Ocular complications are frequent and vision-reducing in MPS.
- Corneal opacification is a major issue in MPS I and MPS VI.
- These findings complicate the diagnosis and management of glaucoma, optic disc changes, and retinopathy in MPS.
More Related Videos
06:15Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
05:42Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection
Published on: August 11, 2023
Related Concept Videos
Proteoglycans
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Desmosomes
Lysosomal Hydrolases
Microbiome of the Eye